Cargando…

Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target

The development of drug resistance is one of the main causes of failure in anti-cancer treatments. Tumor cells adopt many strategies to counteract the action of chemotherapeutic agents, e.g., enhanced DNA damage repair, inactivation of apoptotic pathways, alteration of drug targets, drug inactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Battista, Theo, Fiorillo, Annarita, Chiarini, Valerio, Genovese, Ilaria, Ilari, Andrea, Colotti, Gianni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226229/ https://www.ncbi.nlm.nih.gov/pubmed/32268494 http://dx.doi.org/10.3390/cancers12040887

Ejemplares similares

Sorcin, a Calcium Binding Protein Involved in the Multidrug Resistance Mechanisms in Cancer Cells
por: Colotti, Gianni, et al.
Publicado: (2014)

Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells
por: Genovese, Ilaria, et al.
Publicado: (2017)

Structural basis of Sorcin-mediated calcium-dependent signal transduction
por: Ilari, Andrea, et al.
Publicado: (2015)

Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases
por: Battista, Theo, et al.
Publicado: (2020)

Sorcin is an early marker of neurodegeneration, Ca(2+) dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases
por: Genovese, Ilaria, et al.
Publicado: (2020)

Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways
por: Tito, Claudia, et al.
Publicado: (2023)

Sorcin Links Calcium Signaling to Vesicle Trafficking, Regulates Polo-Like Kinase 1 and Is Necessary for Mitosis
por: Lalioti, Vasiliki S., et al.
Publicado: (2014)

Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin
por: Fiorillo, Annarita, et al.
Publicado: (2021)

Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands
por: Pascarella, Gianmarco, et al.
Publicado: (2023)

Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design
por: Fiorillo, Annarita, et al.
Publicado: (2022)

The Crystal Structures of the Tryparedoxin-Tryparedoxin Peroxidase Couple Unveil the Structural Determinants of Leishmania Detoxification Pathway
por: Fiorillo, Annarita, et al.
Publicado: (2012)

A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition
por: Ilari, Andrea, et al.
Publicado: (2011)

Activation of the cardiac Na(+)–Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains
por: Zamparelli, Carlotta, et al.
Publicado: (2010)

Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells
por: Battista, Theo, et al.
Publicado: (2021)

Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme
por: Turcano, Lorenzo, et al.
Publicado: (2020)

Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening
por: Turcano, Lorenzo, et al.
Publicado: (2018)

Overexpression of sorcin in multidrug-resistant human breast cancer
por: GONG, ZHAOHUA, et al.
Publicado: (2014)

TRAP1 and SORCIN cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma (CRC)
por: Landriscina, Matteo, et al.
Publicado: (2010)

Sorcin a Potential Molecular Target for Cancer Therapy
por: Shabnam, Bano, et al.
Publicado: (2018)

Sorcin: a novel potential target in therapies of cancers
por: Zhou, Xinyi, et al.
Publicado: (2019)

Identification and characterization of the pyridoxal 5’-phosphate allosteric site in Escherichia coli pyridoxine 5’-phosphate oxidase
por: Barile, Anna, et al.
Publicado: (2021)

miR-1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells
por: Deng, Lang-Mei, et al.
Publicado: (2019)

Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking
por: Brindisi, Margherita, et al.
Publicado: (2015)

Sequestration of sorcin by aberrant forms of tau results in the defective calcium homeostasis
por: Kim, Song-In, et al.
Publicado: (2016)

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
por: Marin, Jose J. G., et al.
Publicado: (2019)

Drugging p53 in cancer: one protein, many targets
por: Hassin, Ori, et al.
Publicado: (2022)

Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives
por: Saccoliti, Francesco, et al.
Publicado: (2017)

Pseudo-resistance to anticancer drugs
por: Davoli, Enrico, et al.
Publicado: (2022)

Sorcin induces gastric cancer cell migration and invasion contributing to STAT3 activation
por: Tuo, Huan, et al.
Publicado: (2017)

Sorcin regulate pyroptosis by interacting with NLRP3 inflammasomes to facilitate the progression of hepatocellular carcinoma
por: Li, Zhenfen, et al.
Publicado: (2023)

Structure and metal-binding properties of PA4063, a novel player in periplasmic zinc trafficking by Pseudomonas aeruginosa
por: Fiorillo, Annarita, et al.
Publicado: (2021)

The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug
por: Sacco, Francesca, et al.
Publicado: (2016)

The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma
por: Lu, Enzhou, et al.
Publicado: (2022)

Identification of a novel Sorcin isoform with a different C-terminal but intact dimerization property
por: Tanwar, Supriya, et al.
Publicado: (2023)

The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme
por: Fiorillo, Annarita, et al.
Publicado: (2018)

Immunocytochemical Identification and Localization of the Mr 22,000 Calcium‐binding Protein (Sorcin) in an Adriamycin‐resistant Myelogenous Leukemia Cell Line
por: Sugawara, Isamu, et al.
Publicado: (1989)

Neocytolysis: none, one or many? A reappraisal and future perspectives
por: Risso, Angela, et al.
Publicado: (2014)

Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?
por: Szumilak, Marta, et al.
Publicado: (2021)

One drug to treat many diseases: unlocking the economic trap of rare diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2020)

Drugs Many: Remedies Few
Publicado: (1895)

Cannot write session to /tmp/vufind_sessions/sess_ovcpmtpo0r9aiclvdcieem0m5k